Implications for oxidative and nitrative stress in the pathogenesis of AIDS-related Kaposi's sarcoma

被引:22
作者
Mallery, SR [1 ]
Pei, P
Landwehr, DJ
Clark, CM
Bradburn, JE
Ness, GM
Robertson, FM
机构
[1] Ohio State Univ, Coll Dent, Dept Oral Maxillofacial Surg & Pathol, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA
[3] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA
关键词
D O I
10.1093/carcin/bgh042
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
AIDS-related Kaposi's sarcoma (AIDS-KS), which is the most prevalent AIDS related cancer, arises in a unique environment characterized by profound immunosuppression in conjunction with sustained immunostimulation. Persistent inflammation and the accompanying increased production of reactive species can promote carcinogenesis by numerous routes including sustained cell proliferation, initiation of nuclear and mitochondrial DNA mutations and induction of a proangiogenic environment. Furthermore, during conditions of continuous inflammation, protein nitration can result in irreversible inactivation of enzymes including the cytoprotective and reactive species degrading enzyme, mitochondrial superoxide dismutase (MnSOD). Because MnSOD serves as a putative tumor suppressor gene in addition to its reactive species inactivating capacities, the loss of MnSOD's cytoprotective functions could markedly facilitate malignant transformation. The purpose of this study was to investigate biochemical and molecular pathways by which reactive species facilitate AIDS-KS pathogenesis. Immunohistochemical studies of AIDS-KS tumors showed intense AIDS-KS lesional cell staining for MnSOD, inducible nitric oxide synthase (NOS 2) and the presence of a cellular 'fingerprint' of nitrative stress, 3-nitrotyrosine. Collectively, these results that imply reactive species stress occurs in situ. Similarly, cultured AIDS-KS cells derived from the AIDS-KS tumors contained both MnSOD protein and the 'high output' isoform, NOS 2. Co-localization studies established that the mitochondria are a primary site for 3-nitrotyrosine localization and immunoprecipitation/immunoblotting experiments confirmed that MnSOD tyrosine nitration occurs in AIDS-KS cells. Functional SOD assays showed that AIDS-KS cells possess significantly lower MnSOD activity relative to matched control cells; findings which correspond with ongoing MnSOD tyrosine nitration and subsequent inactivation within AIDS-KS cells. These results, which show in situ evidence of reactive species stress within AIDS-KS tumors and functional deficits attributable to nitrative stress in tumor-derived AIDS-KS lesional cells, imply that reactive species are intimately associated with AIDS-KS pathogenesis and provide insights for development of novel strategies for AIDS-KS clinical treatments.
引用
收藏
页码:597 / 603
页数:7
相关论文
共 40 条
[1]  
ANDERSON JH, 1994, MICROSPHERES REGIONA, P57
[2]   COMPARISON OF CONSTITUTIVE CYTOKINE RELEASE IN HIGH AND LOW HISTOLOGIC GRADE AIDS-RELATED KAPOSIS-SARCOMA CELL STRAINS AND IN SERA FROM HIV+/KS+ AND HIV+/KS+ PATIENTS [J].
BAILER, RT ;
LAZO, A ;
NGBAUTISTA, CL ;
HOUT, BL ;
NESS, GM ;
HEGTVEDT, AK ;
BLAKESLEE, JR ;
STEPHENS, RE ;
BRIERLEY, GP ;
MALLERY, SR .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1995, 15 (05) :473-483
[3]  
BAILER RT, 1995, LYMPHOLOGY, V28, P126
[4]  
BORRELLO S, 2001, J PATHOL, V195, P156
[5]   Pro- and anti-inflammatory cytokines in human immunodeficiency virus infection and acquired immunodeficiency syndrome [J].
Breen, EC .
PHARMACOLOGY & THERAPEUTICS, 2002, 95 (03) :295-304
[6]   The chemistry of DNA damage from nitric oxide and peroxynitrite [J].
Burney, S ;
Caulfield, JL ;
Niles, JC ;
Wishnok, JS ;
Tannenbaum, SR .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1999, 424 (1-2) :37-49
[7]  
Cotran R.S., 1999, ROBBINS PATHOLOGIC B, V6th, P50
[8]  
DUNA H, 2003, ANTIOXID REDOX SIGN, V5, P677
[9]  
FLOHE L, 1984, METHOD ENZYMOL, V105, P93
[10]   Contribution to characterization of oxidative stress in HIV/AIDS patients [J].
Gil, L ;
Martínez, G ;
González, I ;
Tarinas, A ;
Alvarez, A ;
Giuliani, A ;
Molina, R ;
Tápanes, R ;
Pérez, J ;
León, OS .
PHARMACOLOGICAL RESEARCH, 2003, 47 (03) :217-224